Login

Healthcare

00:10:00
Stock News Now for Ascletis Pharma Inc. (HKEX: 1672) | Jinzi J. Wu, PhD , CEO, ASCLETIS PHARMA INC
00:10:00
Online viralgen new facilities sub-eng sin band 1 | Gustavo Pesquin, CEO, ASKLEPIOS BIOPHARMACEUTICAL, INC.
00:10:00
Bill Rancic and Mark Reisenauer Talk About the C3 Award for Cancer Innovation | Mark Reisenauer, PRESIDENT, ASTELLAS PHARMA US, INC
00:10:00
Financial results for the entire year 2021: Pascal Soriot, CEO | Pascal Soriot, CEO OF AstraZeneca INC
00:10:00
The goal of drug developer Atossa Therapeutics is to "transform the breast cancer paradigm." | Steven C. Quay, CEO, ATOSSA THERAPEUTICS INC
00:10:00
Pan-Amyloid Removal Therapeutics by Attralus: A Novel Approach to Systemic Amyloidosis | Mark Timney, CHIEF EXECUTIVE OFFICER, ATTRALUS
00:10:00
NC BioTech CEO Doug Edgeton on Life Sciences Innovations | DOUG EDGETON, PRESIDENT AND CEO OF NORTH CAROLINA BIOTECHNOLOGY CENTER
00:10:00
CEO Spotlight: Leadership Insights from Jason C. Foster of Ori Biotech | JASON C. FOSTER , CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR OF ORI BIOTECH
00:00:00
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D pharma gets green light for phase I clinical trial of Parkinson's disease - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:00:00
Interview with Alan Clarke, CEO Abano Healthcare Limited
00:00:00
Dr. Hartmut Ehrlich, CEO, Abivax
00:00:00
EnterNext welcomes Abivax on Euronext in Paris - Dr. Hartmut Ehrlich, CEO, Abivax

© 2017 - Neuhu+